Our Brands

Life Technologies' Brands

Life Technologies is known for industry-leading brands from reagents to instruments. These include:

Applied Biosystems

Applied Biosystems is a global leader in providing innovative instrument systems to accelerate academic and clinical research, drug discovery and development, pathogen detection, environmental analysis, and forensic DNA analysis.

Applied Biosystems Logo
Invitrogen

Invitrogen offers the broadest range of reagents for scientific research of any brand in the world. Its innovative reagents are used in all major areas of biological discovery including functional genomics, proteomics, stem cells, cell therapy and cell biology.

Invitrogen Logo
Ambion®
RNA & RNA sample prep

Products for the isolation, amplification, and stabilization of RNA.

Dynal®
Magnetic beads for separation

From immunoprecipitation solutions to cutting-edge stem cell isolation kits.

Gateway®
Cloning and protein expression

Technologies to simplify cloning and enable access to virtually any protein expression system.

GIBCO®
Cell culture

The broadest spectrum of high quality cells, media, reagents and sera.

Lipofectamine®
Transfection reagents

Superior delivery, high efficiency and low toxicity for a broad range of cell types.

Molecular Probes®
Fluroescent dyes & probes

The most-referenced fluorescence and imaging technology portfolio to enable cellular exploration.

Novex®
Protein separation and blotting

Gels, stains, standards, and blotting products to tackle every protein analysis challenge.

SuperScript®
RT gene expression

Best-in-class cDNA synthesis, combining maximum yield with maximum sensitivity.

TaqMan®
Real-time PCR

Comprehensive collection of gene-specific primer and probe sets for gene expression studies.

TOPO®
PCR cloning

The fastest, most reliable, and most-referenced cloning technology.

News

  • TGen Study

    LifeTechnologies Corporation announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies. The goal of this first-of-its-kind research collaboration is to demonstrate whether genomic sequencing of cancer tissue can provide clues for treatment strategies for these individuals.

    Read All Close
  • SMS Technology

    Life Technologies Corporation announced early stage results from its single molecule sequencing (SMS) technology. The technology promises to combine virtually unlimited continuous long read lengths with unmatched accuracy to deliver targeted genomic sequence data in a matter of hours, paving the way for sequencing to become a commonplace tool in research laboratories and clinical settings worldwide.

    Read All Close
  • SOLiD PI ANNOUNCED

    Life Technologies Corporation today announced plans for the Applied Biosystems SOLiD(TM) PI System, a new highly accurate, flexible and easy-to-use genomic analysis platform that will bring next-generation sequencing within the grasp of all life science research laboratories worldwide. Early customer adoption of the SOLiD PI System is expected to begin in the second half of 2010.

    Read All Close

Life (Common Stock)